Detalhe da pesquisa
1.
Phenol-Soluble Modulin Peptides Contribute to Influenza A Virus-Associated Staphylococcus aureus Pneumonia.
Infect Immun
; 85(12)2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28893917
2.
The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance.
Cell Microbiol
; 15(7): 1198-211, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23320394
3.
The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cells.
J Virol
; 86(18): 10211-7, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22787206
4.
The adaptor protein FHL2 enhances the cellular innate immune response to influenza A virus infection.
Cell Microbiol
; 14(7): 1135-47, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22417706
5.
Highly pathogenic influenza virus infection of the thymus interferes with T lymphocyte development.
J Immunol
; 185(8): 4824-34, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20861351
6.
Influenza virus infection aggravates stroke outcome.
Stroke
; 42(3): 783-91, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21293018
7.
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.
Front Immunol
; 11: 598444, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33362782
8.
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo.
Antiviral Res
; 142: 178-184, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377100
9.
Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug.
Front Microbiol
; 8: 2130, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29163418
10.
Antiviral activity of Ladania067, an extract from wild black currant leaves against influenza A virus in vitro and in vivo.
Front Microbiol
; 5: 171, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24795704
11.
Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro.
Antiviral Res
; 98(2): 319-24, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23523553
12.
A plant extract of Ribes nigrum folium possesses anti-influenza virus activity in vitro and in vivo by preventing virus entry to host cells.
PLoS One
; 8(5): e63657, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717460
13.
The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
Antiviral Res
; 99(3): 336-44, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23811282
14.
Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo.
J Interferon Cytokine Res
; 31(6): 515-25, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21323570
15.
Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Antiviral Res
; 91(3): 304-13, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21777621
16.
Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
Vaccine
; 26(52): 6965-74, 2008 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-18848593